Pharma 4.0: Revealing Drivers of the Digital Transformation in the Pharma Sector-Reference-Cited by-同舟云学术

Pharma 4.0: Revealing Drivers of the Digital Transformation in the Pharma Sector

Published:2023 Issue: Volume: Page:528-535
ISSN:2195-4356
Container-title:Lecture Notes in Mechanical Engineering
language:
Short-container-title:

Author:

Tetteh Michelle Grace^ORCID,Jagtap Sandeep^ORCID,Salonitis Konstantinos^ORCID

Abstract

AbstractThe primary goal of this paper was to uncover the drivers of digital transformation (DT) in the pharmaceutical industry. The Covid-19 pandemic and tightening regulatory standards in the global pharma industry necessitated pharma executives need to understand the most critical drivers of digitalizing the sector and charting a new path that improves production processes and streamlines these companies’ overall supply chain. This research aims to identify the drivers for DT in the pharmaceutical industry. The Web of Science Core Collection and Scopus gathered relevant data for the research study. The research employs objective analysis to ensure that more reliable conclusions were drawn following the study. The study also proposed that external and internal factors, such as supply chain difficulties and data silos, impact DT adoption in the pharmaceutical sector.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-28839-5_59

Reference21 articles.

1. Ayati, N., Saiyarsarai, P., Nikfar, S.: Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU J. Pharm. Sci. 28(2), 799–805 (2020). https://doi.org/10.1007/s40199-020-00358-5

2. Bedenkov, A., et al.: Developing medical affairs leaders who create the future. Pharm. Med. 34(5), 301–307 (2020). https://doi.org/10.1007/s40290-020-00351-y

3. Lambert, H., et al.: COVID-19 as a global challenge: towards an inclusive and sustainable future. Lancet Planet Health 4, e312–e314 (2020). https://doi.org/10.1016/S2542-5196(20)30168-6

4. Lee, S.L., et al.: Modernizing pharmaceutical manufacturing: from batch to continuous production. J. Pharm. Innov. 10(3), 191–199 (2015). https://doi.org/10.1007/s12247-015-9215-8

5. Trollman, H., Jagtap, S., Garcia-Garcia, G., Harastani, R., Colwill, J., Trollman, F.: COVID-19 demand-induced scarcity effects on nutrition and environment: investigating mitigation strategies for eggs and wheat flour in the United Kingdom. Sustain. Prod. Consum. 27, 1255–1272 (2021). https://doi.org/10.1016/j.spc.2021.03.001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the internal drivers of pharmaceutical company performance in Europe: A DEMATEL analysis;Equilibrium. Quarterly Journal of Economics and Economic Policy;2024-06-30

2. Covid-19 and the South African pharmaceutical supply chain;International Journal of Research in Business and Social Science (2147- 4478);2023-12-11